Use of cerebrosid-kinin in preparation of medicine for preventing and treating peripheral nerve disease
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 诺氏制药(吉林)有限公司
- Publication Date
- 2006-04-26
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
【Technical field】
[0001] The invention relates to the field of medicine, in particular to a new application of cerebroside and carnosine, and more specifically to the application of cerebroside and carnosine in the preparation of drugs for preventing and treating peripheral nerve diseases. 【Background technique】
[0002] Cerebroside and carnosine injection, such as the one produced by Northeast Pharmaceuticals (Jilin) Co., Ltd. (National Drug Approval H22025046), contains active peptides and various active ingredients such as gangliosides. It has been clinically proven that it can promote brain tissue Metabolism, participate in the growth, differentiation and regeneration of brain tissue neurons, improve cerebral blood circulation and brain metabolic function, can be used to treat dysfunction caused by brain diseases, and can be used to treat dementia, traumatic brain injury, cerebral edema and other diseases; It is also used for the treatment of senile dementia, cerebrova...